Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Cidara Therapeutics Stock Crushed It Today

TheMotleyFool

0 0

Why Cidara Therapeutics Stock Crushed It Today: https://g.foolcdn.com/editorial/images/837288/healthcare-professional-inspecting-charts.jpg

The leading pipeline drug being developed by Cidara Therapeutics (NASDAQ: CDTX) got a real boost from a regulator on Thursday, and the biotech's share price moved accordingly. Cidara's stock closed the day more than 12% higher, during a session in which the bellwether S 500 (SNPINDEX: ^GSPC) dropped by 0.3%.

Cidara announced before market open that the U.S. Food and Drug Administration (FDA) has granted the healthcare company's investigational flu drug its Breakthrough Therapy designation. With that tag, the FDA is set to accelerate the approval decision process for the medication.

Image source: Getty Images.

Source Fool.com